GTC
NPSP

Ghost Tree Capital’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Ghost Tree Capital’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-50,000
Closed -$1.65M – 91
2014
Q2 		$1.65M Buy
+50,000
New +$1.44M 1.17% 33

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's NPSP Position: Q3 2014 in Review

Ghost Tree Capital sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 40,000 shares — an estimated $1.32M sold.

Ghost Tree Capital first reported a position in NPSP in Q2 2014 and held it in 1 quarter. The position peaked at $1.32M in Q2 2014. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • Ghost Tree Capital reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 40,000 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.32M.
  • Ghost Tree Capital first reported a position in NPS PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Ghost Tree Capital's NPS PHARMACEUTICALS INC position peaked at $1.32M in Q2 2014.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on Ghost Tree Capital's 13F filing for Q3 2014, filed 14 Nov 2014.